{"database": "lobbying", "table": "lobbying_activities", "rows": [[1260509, "9ee029e2-a4ba-473c-a9e0-d987de866dce", "Q2", "EMERGENT BIOSOLUTIONS INC.", 304931, "EMERGENT BIOSOLUTIONS INC", 2012, "second_quarter", "HOM", "HR 5855 and S 3216 - Department of Homeland Security Appropriations and Departments of Labor, Health and Human Services and Education Appropriations Act for Fiscal Year 2013\nS 3295 - provisions relating to development, acquisition and stockpiling of biodefense vaccines; HR 2356 - WMD Prevention and Preparedness Act of 2011 - provisions relating to acquisition and stockpiling of biodefense vaccines;\nHR 2405 and S 1855 - Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 - entire bill reauthorizing funding and strengthening bioterrorism preparedness programs, including BARDA and the development of MCMs.", "HOUSE OF REPRESENTATIVES,SENATE", null, 710000, 0, 0, "2012-07-11T15:18:59.237000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1260509"], "units": {}, "query_ms": 29.824651952367276, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}